1990 - 1999年纽约市与男性发生性行为和未与男性发生性行为的男性注射吸毒者中艾滋病毒血清流行率及相关行为的变化
Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999.
作者信息
Maslow Carey B, Friedman Samuel R, Perlis Theresa E, Rockwell Russell, Des Jarlais Don C
机构信息
National Development and Research Institutes, Inc, 71 West 23rd Street, New York, NY 10010, USA.
出版信息
Am J Public Health. 2002 Mar;92(3):382-4. doi: 10.2105/ajph.92.3.382.
Abstract
OBJECTIVES
This study examined HIV prevalence and risk behaviors among male injection drug users (IDUs) who have sex with men and among other male IDUs.
METHODS
Male IDUs were interviewed and tested for HIV at a detoxification clinic during 1990 to 1994 and 1995 to 1999. Analyses compared male IDUs who do and do not have sex with men within and between periods.
RESULTS
Initially, HIV seroprevalence and risk behaviors were higher among IDUs who have sex with men. Seroprevalence (initially 60.5% vs 48.3%) declined approximately 15% in both groups, remaining higher among those who have sex with men. Generally, injection prevalence, but not sexual risk behaviors, declined.
CONCLUSIONS
Male IDUs who have sex with men are more likely to engage in higher-risk behaviors and to be HIV infected. Improved intervention approaches for male IDUs who have sex with men are needed.
摘要
目的
本研究调查了男男性行为注射吸毒者以及其他男性注射吸毒者中的艾滋病毒流行情况和风险行为。
方法
1990年至1994年以及1995年至1999年期间，在一家戒毒所对男性注射吸毒者进行了访谈和艾滋病毒检测。分析比较了不同时期内有和没有男男性行为的男性注射吸毒者情况。
结果
最初，男男性行为注射吸毒者中的艾滋病毒血清阳性率和风险行为较高。两组的血清阳性率（最初分别为60.5%和48.3%）均下降了约15%，男男性行为者中的血清阳性率仍较高。一般来说，注射流行率下降了，但性风险行为没有下降。
结论
男男性行为注射吸毒者更有可能从事高风险行为并感染艾滋病毒。需要改进针对男男性行为注射吸毒者的干预方法。
相似文献
1
Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999.
Am J Public Health. 2002 Mar;92(3):382-4. doi: 10.2105/ajph.92.3.382.
2
Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
JAMA. 1994 Jan 12;271(2):121-7.
3
HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.
4
Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City.
AIDS Behav. 2006 Nov;10(6):707-15. doi: 10.1007/s10461-006-9082-x.
5
Correlates of selling sex among male injection drug users in New York City.
Drug Alcohol Depend. 2014 Nov 1;144:78-86. doi: 10.1016/j.drugalcdep.2014.08.010. Epub 2014 Aug 24.
6
HIV seroprevalence and risk behaviors in psychiatric inpatients.
Psychiatry Res. 1991 Nov;39(2):109-14. doi: 10.1016/0165-1781(91)90080-9.
7
Sexual orientation and HIV infection prevalence among young Latino injection drug users in Harlem.
J Womens Health Gend Based Med. 2001 May;10(4):371-80. doi: 10.1089/152460901750269698.
8
"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):158-66. doi: 10.1097/00126334-200402010-00010.
9
High prevalence of HIV infection among young men who have sex with men in New York City.
AIDS. 2000 Aug 18;14(12):1793-800. doi: 10.1097/00002030-200008180-00015.
10
A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Indian J Public Health. 1995 Jul-Sep;39(3):86-92.
引用本文的文献
1
Correlates of Transactional Sex and Violent Victimization among Men Who Inject Drugs in Los Angeles and San Francisco, California.
J Urban Health. 2021 Feb;98(1):70-82. doi: 10.1007/s11524-020-00494-y.
2
HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.
Subst Use Misuse. 2020;55(14):2409-2419. doi: 10.1080/10826084.2020.1823419. Epub 2020 Sep 23.
3
The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.
Int J Drug Policy. 2020 Mar;77:102671. doi: 10.1016/j.drugpo.2020.102671. Epub 2020 Feb 21.
4
Characterizing Men Who Have Sex with Men and Use Injection Drugs in Vancouver, Canada.
AIDS Behav. 2019 Dec;23(12):3324-3330. doi: 10.1007/s10461-019-02605-6.
5
HIV Incidence Among Men Who Have Sex with Men and Inject Drugs in a Canadian Setting.
AIDS Behav. 2018 Dec;22(12):3957-3961. doi: 10.1007/s10461-018-2185-3.
6
Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs.
Epidemiol Infect. 2016 Jun;144(8):1683-700. doi: 10.1017/S0950268815003180. Epub 2016 Jan 12.
7
Evidence for risk reduction among amphetamine-injecting men who have sex with men; results from national HIV behavioral surveillance surveys in the Seattle area 2008-2012.
AIDS Behav. 2014 Oct;18(10):1998-2008. doi: 10.1007/s10461-014-0769-0.
8
A complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategies.
PLoS One. 2012;7(9):e44833. doi: 10.1371/journal.pone.0044833. Epub 2012 Sep 13.
9
High-risk behaviors associated with injection drug use among recently HIV-infected men who have sex with men in San Diego, CA.
AIDS Behav. 2011 Oct;15(7):1561-9. doi: 10.1007/s10461-011-9970-6.
10
HIV and risk environment for injecting drug users: the past, present, and future.
Lancet. 2010 Jul 24;376(9737):268-84. doi: 10.1016/S0140-6736(10)60743-X.
本文引用的文献
1
Understanding HIV risks of chronic drug-using men who have sex with men.
AIDS Care. 1999 Dec;11(6):629-48. doi: 10.1080/09540129947550.
2
HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic.
Am J Public Health. 2000 Mar;90(3):352-9. doi: 10.2105/ajph.90.3.352.
3
Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996.
J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):83-91. doi: 10.1097/00042560-199909010-00011.
4
Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.
J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 1;20(1):67-72. doi: 10.1097/00042560-199901010-00010.
5
Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996.
Am J Public Health. 1998 Dec;88(12):1801-6. doi: 10.2105/ajph.88.12.1801.
6
A multisite study of sexual orientation and injection drug use as predictors of HIV serostatus in out-of-treatment male drug users.
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 1;15(4):289-95. doi: 10.1097/00042560-199708010-00007.
7
Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users.
AIDS. 1993 Dec;7(12):1653-60. doi: 10.1097/00002030-199312000-00017.
8
Applications of data from the CDC Family of Surveys.
Public Health Rep. 1994 Mar-Apr;109(2):204-11.
9
HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1;10(1):90-6.
10
Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium.
Am J Epidemiol. 1995 Oct 15;142(8):864-74. doi: 10.1093/oxfordjournals.aje.a117726.
Zotero 插件